LAMEA Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By End Use (Diagnostic Laboratories, Hospitals & Clinics, and Others), By Type, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Tuberculosis Diagnostics Market would witness market growth of 7.0% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Tuberculosis Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $65.8 million by 2031. The Argentina market is showcasing a CAGR of 7.9% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6.1% during (2024 - 2031).

The market has seen significant advancements in recent years, driven by the continuous development and launch of innovative products by companies committed to combating this health challenge. In addition to improving accuracy, the speed of TB diagnostics has also been a major focus of innovation. Rapid diagnostics are essential in TB control, as they enable healthcare providers to diagnose and initiate treatment promptly, which is crucial for preventing the spread of the disease.

Furthermore, the ongoing innovation in TB diagnostics is not limited to individual products but extends to digital technology integration. Digital data management and analysis platforms are becoming increasingly common in TB diagnostics, allowing for more efficient tracking of cases and treatment outcomes. For example, digital chest X-ray systems equipped with artificial intelligence (AI) algorithms can automatically analyze images and identify signs of TB, assisting healthcare providers in making quicker and more accurate diagnoses. These systems can be particularly useful in screening large populations or settings where trained radiologists are in short supply.

In Saudi Arabia, the demand for tuberculosis diagnostics is influenced by the country’s large expatriate population and the need for effective screening and control measures in densely populated urban centers. The Kingdom has implemented stringent TB screening protocols for expatriates, including mandatory testing for those seeking work visas or residency. This has increased the demand for reliable and rapid diagnostic tools in public health facilities and private clinics. Saudi Arabia’s commitment to improving TB detection, especially in high-risk populations, has driven the adoption of advanced diagnostic methods, including molecular tests and interferon-gamma release assays (IGRAs), to ensure early and accurate diagnosis. Adopting advanced diagnostic technologies, including molecular tests, drug susceptibility testing, and digital radiography, is essential for improving TB detection rates and treatment outcomes. Therefore, as countries in the region continue to enhance their TB control efforts, the demand for effective, reliable, and accessible TB diagnostics is expected to grow, contributing to the overall expansion of the market in LAMEA.

Free Valuable Insights: The Worldwide Tuberculosis Diagnostics Market is Projected to reach USD 3.0 Billion by 2031, at a CAGR of 4.7%

Based on End Use, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Type, the market is segmented into Detection of Latent Infection (Skin Test & IGRA), Phage Assay, Detection of Drug Resistance (DST), Nucleic Acid Testing, Radiographic Method, Cytokine Detection Assay, Diagnostic Laboratory Methods, and Other Methods. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Abbott Laboratories
• Qiagen N.V
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• F.Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Danaher Corporation
• DiaSorin S.p.A.
• Bruker Corporation

LAMEA Tuberculosis Diagnostics Market Report Segmentation

By End Use

• Diagnostic Laboratories
• Hospitals & Clinics
• Others

By Type

• Detection of Latent Infection (Skin Test & IGRA)
• Phage Assay
• Detection of Drug Resistance (DST)
• Nucleic Acid Testing
• Radiographic Method
• Cytokine Detection Assay
• Diagnostic Laboratory Methods
• Other Methods

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Tuberculosis Diagnostics Market, by End Use
1.4.2 LAMEA Tuberculosis Diagnostics Market, by Type
1.4.3 LAMEA Tuberculosis Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Tuberculosis Diagnostics Market by End Use
4.1 LAMEA Diagnostic Laboratories Market by Country
4.2 LAMEA Hospitals & Clinics Market by Country
4.3 LAMEA Others Market by Country

Chapter 5. LAMEA Tuberculosis Diagnostics Market by Type
5.1 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country
5.2 LAMEA Phage Assay Market by Country
5.3 LAMEA Detection of Drug Resistance (DST) Market by Country
5.4 LAMEA Nucleic Acid Testing Market by Country
5.5 LAMEA Radiographic Method Market by Country
5.6 LAMEA Cytokine Detection Assay Market by Country
5.7 LAMEA Diagnostic Laboratory Methods Market by Country
5.8 LAMEA Other Methods Market by Country

Chapter 6. LAMEA Tuberculosis Diagnostics Market by Country
6.1 Brazil Tuberculosis Diagnostics Market
6.1.1 Brazil Tuberculosis Diagnostics Market by End Use
6.1.2 Brazil Tuberculosis Diagnostics Market by Type
6.2 Argentina Tuberculosis Diagnostics Market
6.2.1 Argentina Tuberculosis Diagnostics Market by End Use
6.2.2 Argentina Tuberculosis Diagnostics Market by Type
6.3 UAE Tuberculosis Diagnostics Market
6.3.1 UAE Tuberculosis Diagnostics Market by End Use
6.3.2 UAE Tuberculosis Diagnostics Market by Type
6.4 Saudi Arabia Tuberculosis Diagnostics Market
6.4.1 Saudi Arabia Tuberculosis Diagnostics Market by End Use
6.4.2 Saudi Arabia Tuberculosis Diagnostics Market by Type
6.5 South Africa Tuberculosis Diagnostics Market
6.5.1 South Africa Tuberculosis Diagnostics Market by End Use
6.5.2 South Africa Tuberculosis Diagnostics Market by Type
6.6 Nigeria Tuberculosis Diagnostics Market
6.6.1 Nigeria Tuberculosis Diagnostics Market by End Use
6.6.2 Nigeria Tuberculosis Diagnostics Market by Type
6.7 Rest of LAMEA Tuberculosis Diagnostics Market
6.7.1 Rest of LAMEA Tuberculosis Diagnostics Market by End Use
6.7.2 Rest of LAMEA Tuberculosis Diagnostics Market by Type

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Qiagen N.V.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson, and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.6 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.6 SWOT Analysis
7.6 Hologic, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Danaher Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 DiaSorin S.p.A.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Bruker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Revvity, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis

TABLE 1 LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 4 LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 5 LAMEA Diagnostic Laboratories Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Diagnostic Laboratories Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 12 LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 13 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Detection of Latent Infection (Skin Test & IGRA) Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Phage Assay Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Phage Assay Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Detection of Drug Resistance (DST) Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Detection of Drug Resistance (DST) Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Nucleic Acid Testing Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Nucleic Acid Testing Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Radiographic Method Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Radiographic Method Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Cytokine Detection Assay Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Cytokine Detection Assay Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Diagnostic Laboratory Methods Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Diagnostic Laboratory Methods Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Other Methods Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Other Methods Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Tuberculosis Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Tuberculosis Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 31 Brazil Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 32 Brazil Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 33 Brazil Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 34 Brazil Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 35 Brazil Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 36 Brazil Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 37 Argentina Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 38 Argentina Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 39 Argentina Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 40 Argentina Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 41 Argentina Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 42 Argentina Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 43 UAE Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 44 UAE Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 45 UAE Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 46 UAE Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 47 UAE Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 48 UAE Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 49 Saudi Arabia Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 50 Saudi Arabia Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 51 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 52 Saudi Arabia Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 53 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 54 Saudi Arabia Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 55 South Africa Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 56 South Africa Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 57 South Africa Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 58 South Africa Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 59 South Africa Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 60 South Africa Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 61 Nigeria Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 62 Nigeria Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 63 Nigeria Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 64 Nigeria Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 65 Nigeria Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 66 Nigeria Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 67 Rest of LAMEA Tuberculosis Diagnostics Market, 2020 - 2023, USD Million
TABLE 68 Rest of LAMEA Tuberculosis Diagnostics Market, 2024 - 2031, USD Million
TABLE 69 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2023, USD Million
TABLE 70 Rest of LAMEA Tuberculosis Diagnostics Market by End Use, 2024 - 2031, USD Million
TABLE 71 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2023, USD Million
TABLE 72 Rest of LAMEA Tuberculosis Diagnostics Market by Type, 2024 - 2031, USD Million
TABLE 73 Key Information – Abbott Laboratories
TABLE 74 Key Information – Qiagen N.V.
TABLE 75 Key Information – Thermo Fisher Scientific, Inc.
TABLE 76 Key Information – Becton, Dickinson and Company
TABLE 77 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 78 Key Information – Hologic, Inc.
TABLE 79 Key Information – Danaher Corporation
TABLE 80 Key Information – DiaSorin S.p.A.
TABLE 81 Key Information – Bruker Corporation
TABLE 82 Key Information – Revvity, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Tuberculosis Diagnostics Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Tuberculosis Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Tuberculosis Diagnostics Market
FIG 5 LAMEA Tuberculosis Diagnostics Market share by End Use, 2023
FIG 6 LAMEA Tuberculosis Diagnostics Market share by End Use, 2031
FIG 7 LAMEA Tuberculosis Diagnostics Market by End Use, 2020 - 2031, USD Million
FIG 8 LAMEA Tuberculosis Diagnostics Market share by Type, 2023
FIG 9 LAMEA Tuberculosis Diagnostics Market share by Type, 2031
FIG 10 LAMEA Tuberculosis Diagnostics Market by Type, 2020 - 2031, USD Million
FIG 11 LAMEA Tuberculosis Diagnostics Market share by Country, 2023
FIG 12 LAMEA Tuberculosis Diagnostics Market share by Country, 2031
FIG 13 LAMEA Tuberculosis Diagnostics Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Abbott Laboratories
FIG 15 Swot Analysis: Qiagen N.V.
FIG 16 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 17 SWOT Analysis: Becton, Dickinson and company
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 Swot Analysis: Hologic, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 SWOT Analysis: DiaSorin S.p.A.
FIG 22 Swot Analysis: Bruker Corporation
FIG 23 Swot Analysis: Revvity, Inc.